Avapritinib (Ayvakyt®) for the treatment of indolent systemic mastocytosis (ISM)

Rothschedl, E. and Grössmann, N. (2023): Avapritinib (Ayvakyt®) for the treatment of indolent systemic mastocytosis (ISM). Fact Sheet Nr. 157.

Preview

PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
110kB

Item Type:	Horizon Scanning of Medicines
Subjects:	QU Biochemistry > QU 300-375 Cells QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology QZ Pathology > QZ 200-380 Neoplasms.Cysts WB Practice of medicine > WB 300-962 Therapeutics
Language:	English
Series Name:	Fact Sheet Nr. 157
Deposited on:	18 Dec 2023 15:38
Last Modified:	10 Jul 2025 11:36

Repository Staff Only: item control page